Skip to main content

Vincent Zurawski


Vincent Zurawski has been named CEO of the US subsidiary of Compugen.

Zurawski will direct Compugen’s US operations, based in Princeton, N.J. He will also help develop and implement Compugen’s worldwide business strategy and lead the business and product development of the company’s drug discovery activities.

Following the co-founding of Centocor, a biotechnology company which was recently purchased by Johnson & Johnson, Zurawski founded and was CEO of Apollon, a developer of DNA-based vaccines.

Most recently, Zurawski served as director of research business development at the University of Pennsylvania School of Medicine and Health System, where he was responsible for commercializing intellectual property.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.